AnalystsCarter GouldCarter Gould's Stock Forecasts
AnalystsCarter Gould
Analyst Ranking
Bottom 7%
#3846 out of 4129 analysts
Average Return
-6.18%
Win Rate
52%25 out of 48
Risk vs Reward
Poor
Good
Carter Gould's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | +65.12% | $72.80 | $120.21 | 2022-01-19 - 2022-12-06 | Strong Buy |
Eli Lilly & CoLLY | +57.90% | $180.55 | $285.09 | 2021-04-27 - 2022-04-27 | Strong Buy |
Acceleron Pharma IncXLRN | +57.28% | $86.57 | $136.16 | 2020-02-26 - 2021-02-26 | Strong Buy |
Acceleron Pharma IncXLRN | +46.29% | $30.07 | $43.99 | 2017-03-08 - 2018-03-09 | Strong Buy |
Eli Lilly & CoLLY | +39.87% | $263.48 | $368.54 | 2021-12-19 - 2022-12-06 | Strong Buy |
Carter Gould's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 15 | Hold | $313.00 | +7.39% | Maintains | 8 days ago |
Vor Biopharma IncVOR | 2 | Strong Buy | $15.00 | +248.84% | Maintains | a month ago |
Molecular Templates IncMTEM | 2 | Strong Buy | $1.00 | +98.81% | Maintains | a month ago |
Reata Pharmaceuticals IncRETA | 3 | Strong Buy | $50.00 | +32.77% | Maintains | a month ago |
Pfizer IncPFE | 5 | Hold | $49.00 | -1.43% | Maintains | a month ago |
Eli Lilly & CoLLY | 4 | Strong Buy | $395.00 | +7.18% | Maintains | a month ago |
Abbvie IncABBV | 6 | Hold | $155.00 | -5.33% | Maintains | a month ago |
Gilead Sciences IncGILD | 6 | Hold | $76.00 | -13.60% | Upgrades | a month ago |
Amgen IncAMGN | 7 | Strong Sell | $234.00 | -17.40% | Downgrades | a month ago |
Merck & Co IncMRK | 5 | Strong Buy | $110.00 | +0.98% | Maintains | a month ago |
Bristol Myers Squibb CoBMY | 5 | Hold | $66.00 | -17.42% | Maintains | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 5 | Strong Buy | $815.00 | +9.03% | Maintains | 3 months ago |
Gossamer Bio IncGOSS | 3 | Strong Buy | $18.00 | +662.71% | Maintains | 4 months ago |
Applied Therapeutics IncAPLT | 4 | Hold | $2.25 | +161.63% | Maintains | 4 months ago |
Neurocrine Biosciences IncNBIX | 4 | Strong Buy | $113.00 | -6.00% | Maintains | 4 months ago |
Allakos IncALLK | 2 | Strong Sell | $2.50 | -68.55% | Maintains | 7 months ago |
Alector IncALEC | 1 | Strong Buy | $14.00 | +51.02% | Maintains | 7 months ago |
Paycom Software IncPAYC | 1 | Hold | $380.00 | +21.53% | Maintains | a year ago |
Travere Therapeutics IncTVTX | 1 | Strong Buy | $40.00 | +99.00% | Maintains | a year ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | a year ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Incyte CorpINCY | 3 | Hold | $82.00 | N/A | Downgrades | 4 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | $188.00 | N/A | Maintains | 4 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.